Next generation DNA sequencing and the future of genomic medicine

Genes

Volumn 1, Issue 1, 2010, Pages 38-69

  Anderson, Matthew W ^a   Schrijver, Iris ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioinformatics; DNA; Molecular diagnostics; Next generation sequencing; Sequencing

Indexed keywords

GENOMIC DNA; TRANSCRIPTOME;

ANALYTICAL EQUIPMENT; COMPUTER PROGRAM; COPY NUMBER VARIATION; DIAGNOSTIC ACCURACY; DNA LIBRARY; DNA SEQUENCE; EPIGENETICS; GENE AMPLIFICATION; GENE TECHNOLOGY; GENETIC ANALYSIS; GENETIC DISORDER; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; INFORMATION PROCESSING; METAGENOMICS; MINIMAL RESIDUAL DISEASE; NONHUMAN; PERSONALIZED MEDICINE; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

EID: 79952080610     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes1010038     Document Type: Review

References (130)

1. Maxam, A.M.; Gilbert, W. A new method for sequencing DNA. Proc. Natl. Acad. Sci. U. S. A. 1977, 74, 560-564.
2. Sanger, F.; Nicklen, S.; Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U. S. A. 1977, 74, 5463-5467.
3. Smith, L.M.; Sanders, J.Z.; Kaiser, R.J.; Hughes, P.; Dodd, C.; Connell, C.R.; Heiner, C.; Kent, S.B.; Hood, L.E. Fluorescence detection in automated DNA sequence analysis. Nature 1986, 321, 674-679.
4. Gocayne, J.; Robinson, D.A.; FitzGerald, M.G.; Chung, F.Z.; Kerlavage, A.R.; Lentes, K.U.; Lai, J.; Wang, C.D.; Fraser, C.M.; Venter, J.C. Primary structure of rat cardiac beta-adrenergic and muscarinic cholinergic receptors obtained by automated DNA sequence analysis: further evidence for a multigene family. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 8296-8300.
5. Lander, E.S.; Linton, L.M.; Birren, B.; Nusbaum, C.; Zody, M.C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; Fitz Hugh, W.; et al. Initial sequencing and analysis of the human genome. Nature 2001, 409, 860-921.
6. Venter, J.C.; Adams, M.D.; Myers, E.W.; Li, P.W.; Mural, R.J.; Sutton, G.G.; Smith, H.O.; Yandell, M.; Evans, C.A.; Holt R.A., et al. The sequence of the human genome. Science 2001, 291, 1304-1351.
7. Emrich, C.A.; Tian, H.; Medintz, I.L.; Mathies, R.A. Microfabricated 384-lane capillary array electrophoresis bioanalyzer for ultrahigh-throughput genetic analysis. Anal. Chem. 2002, 74, 5076-5083.
8. Kommedal, O.; Karlsen, B.; Saebo, O. Analysis of mixed sequencing chromatograms and its application in direct 16S rRNA gene sequencing of polymicrobial samples. J. Clin. Microbiol. 2008, 46, 3766-3771.
9. Margulies, M.; Egholm, M.; Altman, W.E.; Attiya, S.; Bader, J.S.; Bemben, L.A.; Berka, J.; Braverman, M.S.; Chen, Y.J.; Chen, Z., et al. Genome sequencing in microfabricated highdensity picolitre reactors. Nature 2005, 437, 376-380.
10. Ronaghi, M.; Karamohamed, S.; Pettersson, B.; Uhlen, M.; Nyren, P. Real-time DNA sequencing using detection of pyrophosphate release. Anal. Biochem. 1996, 242, 84-89.
11. Ronaghi, M.; Uhlen, M.; Nyren, P. A sequencing method based on real-time pyrophosphate. Science 1998, 281, 363, 365.
12. Shendure, J.; Porreca, G.J.; Reppas, N.B.; Lin, X.; McCutcheon, J.P.; Rosenbaum, A.M.; Wang, M.D.; Zhang, K.; Mitra, R.D.; Church, G.M. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 2005, 309, 1728-1732.
13. The Church Laboratory. Polony sequencing protocols. http://openwetware.org/wiki/Church_Lab:PoloProt (accessed April 2010).
14. Drmanac, R.; Sparks, A.B.; Callow, M.J.; Halpern, A.L.; Burns, N.L.; Kermani, B.G.; Carnevali, P.; Nazarenko, I.; Nilsen, G.B.; Yeung, G., et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010, 327, 78-81.
15. Adessi, C.; Matton, G.; Ayala, G.; Turcatti, G.; Mermod, J.J.; Mayer, P.; Kawashima, E. Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms. Nucleic Acids Res. 2000, 28, E87.
16. Fedurco, M.; Romieu, A.; Williams, S.; Lawrence, I.; Turcatti, G. BTA, a novel reagent for DNA attachment on glass and efficient generation of solid-phase amplified DNA colonies. Nucleic Acids Res. 2006, 34, e22.
17. Bentley, D.R.; Balasubramanian, S.; Swerdlow, H.P.; Smith, G.P.; Milton, J.; Brown, C.G.; Hall, K.P.; Evers, D.J.; Barnes, C.L.; Bignell, H.R., et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008, 456, 53-59.
18. Quail, M.A.; Kozarewa, I.; Smith, F.; Scally, A.; Stephens, P.J.; Durbin, R.; Swerdlow, H.; Turner, D.J. A large genome center's improvements to the Illumina sequencing system. Nat. Methods 2008, 5, 1005-1010.
19. Braslavsky, I.; Hebert, B.; Kartalov, E.; Quake, S.R. Sequence information can be obtained from single DNA molecules. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 3960-3964.
20. Harris, T.D.; Buzby, P.R.; Babcock, H.; Beer, E.; Bowers, J.; Braslavsky, I.; Causey, M.; Colonell, J.; Dimeo, J.; Efcavitch, J.W.; Giladi, E.; Gill, J.; Healy, J.; Jarosz, M.; Lapen, D.; Moulton, K.; Quake, S.R.; Steinmann, K.; Thayer, E.; Tyurina, A.; Ward, R.; Weiss, H.; Xie, Z. Single-molecule DNA sequencing of a viral genome. Science 2008, 320, 106-109.
21. Pushkarev, D.; Neff, N.F.; Quake, S.R. Single-molecule sequencing of an individual human genome. Nat. Biotechnol. 2009, 27, 847-852.
22. Bowers, J.; Mitchell, J.; Beer, E.; Buzby, P.R.; Causey, M.; Efcavitch, J.W.; Jarosz, M.; Krzymanska-Olejnik, E.; Kung, L.; Lipson, D.; Lowman, G.M.; Marappan, S.; McInerney, P.; Platt, A.; Roy, A.; Siddiqi, S.M.; Steinmann, K.; Thompson, J.F. Virtual terminator nucleotides for next-generation DNA sequencing. Nat. Methods 2009, 6, 593-595.
23. Branton, D.; Deamer, D.W.; Marziali, A.; Bayley, H.; Benner, S.A.; Butler, T.; Di Ventra, M.; Garaj, S.; Hibbs, A.; Huang, X.; Jovanovich, S.B.; Krstic, P.S.; Lindsay, S.; Ling, X.S.; Mastrangelo, C.H.; Meller, A.; Oliver, J.S.; Pershin, Y.V.; Ramsey, J.M.; Riehn, R.; Soni, G.V.; Tabard-Cossa, V.; Wanunu, M.; Wiggin, M.; Schloss, J.A. The potential and challenges of nanopore sequencing. Nat. Biotechnol. 2008, 26, 1146-1153.
24. Eid, J.; Fehr, A.; Gray, J.; Luong, K.; Lyle, J.; Otto, G.; Peluso, P.; Rank, D.; Baybayan, P.; Bettman, B., et al. Real-time DNA sequencing from single polymerase molecules. Science 2009, 323, 133-138.
25. Flusberg, B.A.; Webster, D.R.; Lee, J.H.; Travers, K.J.; Olivares, E.C.; Clark, T.A.; Korlach, J.; Turner, S.W. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat. Methods DOI:10.1038/NMETH.1459. Published Online: 9 May 2010. http://www.nature.com/naturemethods (accessed May 2010).
26. The X PRIZE Foundation. Archon X PRIZE for genomics. http://genomics.xprize.org (accessed April 2010).
27. Turner, E.H.; Ng, S.B.; Nickerson, D.A.; Shendure, J. Methods for genomic partitioning. Annu. Rev. Genomics Hum. Genet. 2009, 10, 263-284.
28. Meuzelaar, L.S.; Lancaster, O.; Pasche, J.P.; Kopal, G.; Brookes, A.J. MegaPlex PCR: a strategy for multiplex amplification. Nat. Methods 2007, 4, 835-837.
29. Varley, K.E.; Mitra, R.D. Nested Patch PCR enables highly multiplexed mutation discovery in candidate genes. Genome Res. 2008, 18, 1844-1850.
30. Dahl, F.; Stenberg, J.; Fredriksson, S.; Welch, K.; Zhang, M.; Nilsson, M.; Bicknell, D.; Bodmer, W.F.; Davis, R.W.; Ji, H. Multigene amplification and massively parallel sequencing for cancer mutation discovery. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 9387-9392.
31. Hodges, E.; Xuan, Z.; Balija, V.; Kramer, M.; Molla, M.N.; Smith, S.W.; Middle, C.M.; Rodesch, M.J.; Albert, T.J.; Hannon, G.J.; McCombie, W.R. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 2007, 39, 1522-1527.
32. Ng, S.B.; Buckingham, K.J.; Lee, C.; Bigham, A.W.; Tabor, H.K.; Dent, K.M.; Huff, C.D.; Shannon, P.T.; Jabs, E.W.; Nickerson, D.A.; Shendure, J.; Bamshad, M.J. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42, 30-35.
33. Huse, S.M.; Huber, J.A.; Morrison, H.G.; Sogin, M.L.; Welch, D.M. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 2007, 8, R143.
34. Flicek, P.; Birney, E. Sense from sequence reads: methods for alignment and assembly. Nat. Methods 2009, 6, S6-S12.
35. Idury, R.M.; Waterman, M.S. A new algorithm for DNA sequence assembly. J. Comput. Biol. 1995, 2, 291-306.
36. Simpson, J.T.; Wong, K.; Jackman, S.D.; Schein, J.E.; Jones, S.J.; Birol, I. ABySS: a parallel assembler for short read sequence data. Genome Res. 2009, 19, 1117-1123.
37. Manolio, T.A.; Collins, F.S. The HapMap and genome-wide association studies in diagnosis and therapy. Annu. Rev. Med. 2009, 60, 443-456.
38. A haplotype map of the human genome. Nature 2005, 437, 1299-1320.
39. Frazer, K.A.; Ballinger, D.G.; Cox, D.R.; Hinds, D.A.; Stuve, L.L.; Gibbs, R.A.; Belmont, J.W.; Boudreau, A.; Hardenbol, P.; Leal, S.M., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449, 851-861.
40. LaFramboise, T. Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances. Nucleic Acids Res. 2009, 37, 4181-4193.
41. Van Tassell, C.P.; Smith, T.P.; Matukumalli, L.K.; Taylor, J.F.; Schnabel, R.D.; Lawley, C.T.; Haudenschild, C.D.; Moore, S.S.; Warren, W.C.; Sonstegard, T.S. SNP discovery and allele frequency estimation by deep sequencing of reduced representation libraries. Nat. Methods 2008, 5, 247-252.
42. Li, R.; Li, Y.; Fang, X.; Yang, H.; Wang, J.; Kristiansen, K. SNP detection for massively parallel whole-genome resequencing. Genome Res. 2009, 19, 1124-1132.
43. Qin, W.; Kozlowski, P.; Taillon, B.E.; Bouffard, P.; Holmes, A.J.; Janne, P.; Camposano, S.; Thiele, E.; Franz, D.; Kwiatkowski, D.J. Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex. Hum. Genet. 2010, 127, 573-582.
44. The 1000 Genomes Project. 1000 genomes: a deep catalog of human variation. http://www.1000genomes.org/page.php (accessed April 2010).
45. Lupski, J.R.; Reid, J.G.; Gonzaga-Jauregui, C.; Rio Deiros, D.; Chen, D.C.; Nazareth, L.; Bainbridge, M.; Dinh, H.; Jing, C.; Wheeler, D.A.; McGuire, A.L.; Zhang, F.; Stankiewicz, P.; Halperin, J.J.; Yang, C.; Gehman, C.; Guo, D.; Irikat, R.K.; Tom, W.; Fantin, N.J.; Muzny, D.M.; Gibbs, R.A. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med. 2010, 362, 1181-1191.
46. Roach, J.C.; Glusman, G.; Smit, A.F.; Huff, C.D.; Hubley, R.; Shannon, P.T.; Rowen, L.; Pant, K.P.; Goodman, N.; Bamshad, M.; Shendure, J.; Drmanac, R.; Jorde, L.B.; Hood, L.; Galas, D.J. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010, 328, 636-639.
47. Ley, T.J.; Mardis, E.R.; Ding, L.; Fulton, B.; McLellan, M.D.; Chen, K.; Dooling, D.; Dunford- Shore, B.H.; McGrath, S.; Hickenbotham, M., et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008, 456, 66-72.
48. Mardis, E.R.; Ding, L.; Dooling, D.J.; Larson, D.E.; McLellan, M.D.; Chen, K.; Koboldt, D.C.; Fulton, R.S.; Delehaunty, K.D.; McGrath, S.D., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 2009, 361, 1058-1066.
49. Pleasance, E.D.; Stephens, P.J.; O'Meara, S.; McBride, D.J.; Meynert, A.; Jones, D.; Lin, M.L.; Beare, D.; Lau, K.W.; Greenman, C., et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010, 463, 184-190.
50. Pleasance, E.D.; Cheetham, R.K.; Stephens, P.J.; McBride, D.J.; Humphray, S.J.; Greenman, C.D.; Varela, I.; Lin, M.L.; Ordonez, G.R.; Bignell, G.R., et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010, 463, 191-196.
51. International Cancer Genome Consortium. International cancer genome consortium overview. http://www.icgc.org (accessed April 2010).
52. Sabeti, P.C.; Varilly, P.; Fry, B.; Lohmueller, J.; Hostetter, E.; Cotsapas, C.; Xie, X.; Byrne, E.H.; McCarroll, S.A.; Gaudet, R., et al. Genome-wide detection and characterization of positive selection in human populations. Nature 2007, 449, 913-918.
53. Petersdorf, E.W. HLA matching in allogeneic stem cell transplantation. Curr. Opin. Hematol. 2004, 11, 386-391.
54. Gabriel, C.; Danzer, M.; Hackl, C.; Kopal, G.; Hufnagl, P.; Hofer, K.; Polin, H.; Stabentheiner, S.; Proll, J. Rapid high-throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification. Hum. Immunol. 2009, 70, 960-964.
55. Bentley, G.; Higuchi, R.; Hoglund, B.; Goodridge, D.; Sayer, D.; Trachtenberg, E.A.; Erlich, H.A. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 2009, 74, 393-403.
56. Iafrate, A.J.; Feuk, L.; Rivera, M.N.; Listewnik, M.L.; Donahoe, P.K.; Qi, Y.; Scherer, S.W.; Lee, C. Detection of large-scale variation in the human genome. Nat. Genet. 2004, 36, 949-951.
57. Sebat, J.; Lakshmi, B.; Troge, J.; Alexander, J.; Young, J.; Lundin, P.; Maner, S.; Massa, H.; Walker, M.; Chi, M.; Navin, N.; Lucito, R.; Healy, J.; Hicks, J.; Ye, K.; Reiner, A.; Gilliam, T.C.; Trask, B.; Patterson, N.; Zetterberg, A.; Wigler, M. Large-scale copy number polymorphism in the human genome. Science 2004, 305, 525-528.
58. Stankiewicz, P.; Lupski, J.R. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 2010, 61, 437-455.
59. Zhang, F.; Gu, W.; Hurles, M.E.; Lupski, J.R. Copy number variation in human health, disease, and evolution. Annu. Rev. Genomics Hum. Genet. 2009, 10, 451-481.
60. Korbel, J.O.; Urban, A.E.; Affourtit, J.P.; Godwin, B.; Grubert, F.; Simons, J.F.; Kim, P.M.; Palejev, D.; Carriero, N.J.; Du, L.; Taillon, B.E.; Chen, Z.; Tanzer, A.; Saunders, A.C.; Chi, J.; Yang, F.; Carter, N.P.; Hurles, M.E.; Weissman, S.M.; Harkins, T.T.; Gerstein, M.B.; Egholm, M.; Snyder, M. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007, 318, 420-426.
61. Campbell, P.J.; Stephens, P.J.; Pleasance, E.D.; O'Meara, S.; Li, H.; Santarius, T.; Stebbings, L.A.; Leroy, C.; Edkins, S.; Hardy, C.; Teague, J.W.; Menzies, A.; Goodhead, I.; Turner, D.J.; Clee, C.M.; Quail, M.A.; Cox, A.; Brown, C.; Durbin, R.; Hurles, M.E.; Edwards, P.A.; Bignell, G.R.; Stratton, M.R.; Futreal, P.A. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat. Genet. 2008, 40, 722-729.
62. Stephens, P.J.; McBride, D.J.; Lin, M.L.; Varela, I.; Pleasance, E.D.; Simpson, J.T.; Stebbings, L.A.; Leroy, C.; Edkins, S.; Mudie, L.J., et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009, 462, 1005-1010.
63. Lopez, J.; Percharde, M.; Coley, H.M.; Webb, A.; Crook, T. The context and potential of epigenetics in oncology. Br. J. Cancer 2009, 100, 571-577.
64. Aggerholm, A.; Holm, M.S.; Guldberg, P.; Olesen, L.H.; Hokland, P. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur. J. Haematol. 2006, 76, 23-32.
65. Kane, M.F.; Loda, M.; Gaida, G.M.; Lipman, J.; Mishra, R.; Goldman, H.; Jessup, J.M.; Kolodner, R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997, 57, 808-811.
66. Hegi, M.E.; Diserens, A.C.; Gorlia, T.; Hamou, M.F.; de Tribolet, N.; Weller, M.; Kros, J.M.; Hainfellner, J.A.; Mason, W.; Mariani, L.; Bromberg, J.E.; Hau, P.; Mirimanoff, R.O.; Cairncross, J.G.; Janzer, R.C.; Stupp, R. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 2005, 352, 997-1003.
67. Meissner, A.; Mikkelsen, T.S.; Gu, H.; Wernig, M.; Hanna, J.; Sivachenko, A.; Zhang, X.; Bernstein, B.E.; Nusbaum, C.; Jaffe, D.B.; Gnirke, A.; Jaenisch, R.; Lander, E.S. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008, 454, 766-770.
68. Korshunova, Y.; Maloney, R.K.; Lakey, N.; Citek, R.W.; Bacher, B.; Budiman, A.; Ordway, J.M.; McCombie, W.R.; Leon, J.; Jeddeloh, J.A.; McPherson, J.D. Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosinemethylation patterns obtained from tissue and serum DNA. Genome Res. 2008, 18, 19-29.
69. Piekarz, R.L.; Bates, S.E. Epigenetic modifiers: basic understanding and clinical development. Clin. Cancer Res. 2009, 15, 3918-3926.
70. Solomon, M.J.; Larsen, P.L.; Varshavsky, A. Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell 1988, 53, 937-947.
71. Ren, B.; Robert, F.; Wyrick, J.J.; Aparicio, O.; Jennings, E.G.; Simon, I.; Zeitlinger, J.; Schreiber, J.; Hannett, N.; Kanin, E.; Volkert, T.L.; Wilson, C.J.; Bell, S.P.; Young, R.A. Genome-wide location and function of DNA binding proteins. Science 2000, 290, 2306-2309.
72. Park, P.J. ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet. 2009, 10, 669-680.
73. Barski, A.; Cuddapah, S.; Cui, K.; Roh, T.Y.; Schones, D.E.; Wang, Z.; Wei, G.; Chepelev, I.; Zhao, K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129, 823-837.
74. Robertson, G.; Hirst, M.; Bainbridge, M.; Bilenky, M.; Zhao, Y.; Zeng, T.; Euskirchen, G.; Bernier, B.; Varhol, R.; Delaney, A.; Thiessen, N.; Griffith, O.L.; He, A.; Marra, M.; Snyder, M.; Jones, S. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 2007, 4, 651-657.
75. Mikkelsen, T.S.; Ku, M.; Jaffe, D.B.; Issac, B.; Lieberman, E.; Giannoukos, G.; Alvarez, P.; Brockman, W.; Kim, T.K.; Koche, R.P.; Lee, W.; Mendenhall, E.; O'Donovan, A.; Presser, A.; Russ, C.; Xie, X.; Meissner, A.; Wernig, M.; Jaenisch, R.; Nusbaum, C.; Lander, E.S.; Bernstein, B.E. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448, 553-560.
76. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57-70.
77. Segal, E.; Friedman, N.; Koller, D.; Regev, A. A module map showing conditional activity of expression modules in cancer. Nat. Genet. 2004, 36, 1090-1098.
78. van de Vijver, M.J.; He, Y.D.; van't Veer, L.J.; Dai, H.; Hart, A.A.; Voskuil, D.W.; Schreiber, G.J.; Peterse, J.L.; Roberts, C.; Marton, M.J.; Parrish, M.; Atsma, D.; Witteveen, A.; Glas, A.; Delahaye, L.; van der Velde, T.; Bartelink, H.; Rodenhuis, S.; Rutgers, E.T.; Friend, S.H.; Bernards, R. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002, 347, 1999-2009.
79. Paik, S.; Shak, S.; Tang, G.; Kim, C.; Baker, J.; Cronin, M.; Baehner, F.L.; Walker, M.G.; Watson, D.; Park, T.; Hiller, W.; Fisher, E.R.; Wickerham, D.L.; Bryant, J.; Wolmark, N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 2004, 351, 2817-2826.
80. Lipshutz, R.J.; Fodor, S.P.; Gingeras, T.R.; Lockhart, D.J. High density synthetic oligonucleotide arrays. Nat. Genet. 1999, 21, 20-24.
81. Schena, M.; Shalon, D.; Davis, R.W.; Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270, 467-470.
82. Tinker, A.V.; Boussioutas, A.; Bowtell, D.D. The challenges of gene expression microarrays for the study of human cancer. Cancer Cell 2006, 9, 333-339.
83. Wang, Z.; Gerstein, M.; Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10, 57-63.
84. Beck, A.H.; Weng, Z.; Witten, D.M.; Zhu, S.; Foley, J.W.; Lacroute, P.; Smith, C.L.; Tibshirani, R.; van de Rijn, M.; Sidow, A.; West, R.B. 3'-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One 2010, 5, e8768.
85. Sultan, M.; Schulz, M.H.; Richard, H.; Magen, A.; Klingenhoff, A.; Scherf, M.; Seifert, M.; Borodina, T.; Soldatov, A.; Parkhomchuk, D.; Schmidt, D.; O'Keeffe, S.; Haas, S.; Vingron, M.; Lehrach, H.; Yaspo, M.L. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008, 321, 956-960.
86. Morin, R.; Bainbridge, M.; Fejes, A.; Hirst, M.; Krzywinski, M.; Pugh, T.; McDonald, H.; Varhol, R.; Jones, S.; Marra, M. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques 2008, 45, 81-94.
87. Maher, C.A.; Kumar-Sinha, C.; Cao, X.; Kalyana-Sundaram, S.; Han, B.; Jing, X.; Sam, L.; Barrette, T.; Palanisamy, N.; Chinnaiyan, A.M. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458, 97-101.
88. Shah, S.P.; Kobel, M.; Senz, J.; Morin, R.D.; Clarke, B.A.; Wiegand, K.C.; Leung, G.; Zayed, A.; Mehl, E.; Kalloger, S.E., et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N. Engl. J. Med. 2009, 360, 2719-2729.
89. Nygaard, S.; Jacobsen, A.; Lindow, M.; Eriksen, J.; Balslev, E.; Flyger, H.; Tolstrup, N.; Moller, S.; Krogh, A.; Litman, T. Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing. BMC Med. Genomics 2009, 2, 35.
90. Wyman, S.K.; Parkin, R.K.; Mitchell, P.S.; Fritz, B.R.; O'Briant, K.; Godwin, A.K.; Urban, N.; Drescher, C.W.; Knudsen, B.S.; Tewari, M. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One 2009, 4, e5311.
91. Uziel, T.; Karginov, F.V.; Xie, S.; Parker, J.S.; Wang, Y.D.; Gajjar, A.; He, L.; Ellison, D.; Gilbertson, R.J.; Hannon, G.; Roussel, M.F. The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 2812-2817.
92. Sharma, C.M.; Hoffmann, S.; Darfeuille, F.; Reignier, J.; Findeiss, S.; Sittka, A.; Chabas, S.; Reiche, K.; Hackermuller, J.; Reinhardt, R.; Stadler, P.F.; Vogel, J. The primary transcriptome of the major human pathogen Helicobacter pylori. Nature 2010, 464, 250-255.
93. Montgomery, S.B.; Sammeth, M.; Gutierrez-Arcelus, M.; Lach, R.P.; Ingle, C.; Nisbett, J.; Guigo, R.; Dermitzakis, E.T. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 2010, 464, 773-777.
94. Pickrell, J.K.; Marioni, J.C.; Pai, A.A.; Degner, J.F.; Engelhardt, B.E.; Nkadori, E.; Veyrieras, J.B.; Stephens, M.; Gilad, Y.; Pritchard, J.K. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 2010, 464, 768-772.
95. Muldrew, K.L. Molecular diagnostics of infectious diseases. Curr. Opin. Pediatr. 2009, 21, 102-111.
96. Petrosino, J.F.; Highlander, S.; Luna, R.A.; Gibbs, R.A.; Versalovic, J. Metagenomic pyrosequencing and microbial identification. Clin. Chem. 2009, 55, 856-866.
97. Palacios, G.; Druce, J.; Du, L.; Tran, T.; Birch, C.; Briese, T.; Conlan, S.; Quan, P.L.; Hui, J.; Marshall, J.; Simons, J.F.; Egholm, M.; Paddock, C.D.; Shieh, W.J.; Goldsmith, C.S.; Zaki, S.R.; Catton, M.; Lipkin, W.I. A new arenavirus in a cluster of fatal transplant-associated diseases. N. Engl. J. Med. 2008, 358, 991-998.
98. Margeridon-Thermet, S.; Shulman, N.S.; Ahmed, A.; Shahriar, R.; Liu, T.; Wang, C.; Holmes, S.P.; Babrzadeh, F.; Gharizadeh, B.; Hanczaruk, B.; Simen, B.B.; Egholm, M.; Shafer, R.W. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J. Infect. Dis. 2009, 199, 1275-1285.
99. Le, T.; Chiarella, J.; Simen, B.B.; Hanczaruk, B.; Egholm, M.; Landry, M.L.; Dieckhaus, K.; Rosen, M.I.; Kozal, M.J. Low-abundance HIV drug-resistant viral variants in treatmentexperienced persons correlate with historical antiretroviral use. PLoS One 2009, 4, e6079.
100. Nakamura, S.; Maeda, N.; Miron, I.M.; Yoh, M.; Izutsu, K.; Kataoka, C.; Honda, T.; Yasunaga, T.; Nakaya, T.; Kawai, J.; Hayashizaki, Y.; Horii, T.; Iida, T. Metagenomic diagnosis of bacterial infections. Emerg. Infect. Dis. 2008, 14, 1784-1786.
101. Radich, J.P.; Zelenetz, A.D.; Chan, W.C.; Croce, C.M.; Czuczman, M.S.; Erba, H.P.; Horning, S.J.; Houldsworth, J.; Smith, B.D.; Snyder, D.S.; Sundar, H.M.; Wetzler, M.; Winter, J.N. NCCN task force report: molecular markers in leukemias and lymphomas. J. Natl. Compr. Canc. Netw. 2009, 7 (Suppl. 4), S1-34, quiz S35-36.
102. Allan, A.L.; Keeney, M. Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J. Oncol. 2010, 2010, 426218.
103. Druker, B.J. Translation of the Philadelphia chromosome into therapy for CML. Blood 2008, 112, 4808-4817.
104. Leary, R.J.; Kinde, I.; Diehl, F.; Schmidt, K.; Clouser, C.; Duncan, C.; Antipova, A.; Lee, C.; McKernan, K.; De La Vega, F.M.; Kinzler, K.W.; Vogelstein, B.; Diaz, L.A., Jr.; Velculescu, V.E. Development of personalized tumor biomarkers using massively parallel sequencing. Sci. Transl. Med. 2010, 2, 20ra14.
105. Boyd, S.D.; Marshall, E.L.; Merker, J.D.; Maniar, J.M.; Zhang, L.N.; Sahaf, B.; Jones, C.D.; Simen, B.B.; Hanczaruk, B.; Nguyen, K.D.; Nadeau, K.C.; Egholm, M.; Miklos, D.B.; Zehnder, J.L.; Fire, A.Z. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci. Transl. Med. 2009, 1, 12ra23.
106. Parameswaran, P.; Jalili, R.; Tao, L.; Shokralla, S.; Gharizadeh, B.; Ronaghi, M.; Fire, A.Z. A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing. Nucleic Acids Res. 2007, 35, e130.
107. Elstein, A.S.; Schwartz, A. Clinical problem solving and diagnostic decision making: selective review of the cognitive literature. Brit. Med. J. 2002, 324, 729-732.
108. Isler, J.A.; Vesterqvist, O.E.; Burczynski, M.E. Analytical validation of genotyping assays in the biomarker laboratory. Pharmacogenomics 2007, 8, 353-368.
109. Pabst, T.; Mueller, B.U. Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clin. Cancer Res. 2009, 15, 5303-5307.
110. Schrijver, I. Hereditary non-syndromic sensorineural hearing loss: transforming silence to sound. J. Mol. Diagn. 2004, 6, 275-284.
111. Kelsell, D.P.; Dunlop, J.; Stevens, H.P.; Lench, N.J.; Liang, J.N.; Parry, G.; Mueller, R.F.; Leigh, I.M. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997, 387, 80-83.
112. Ballana, E.; Ventayol, M.; Rabionet, R.; Gasparini, P.; Estivill, X. Connexins and deafness homepage. http://davinci.crg.es/deafness/index.php (accessed April 2010).
113. White, T.W.; Deans, M.R.; Kelsell, D.P.; Paul, D.L. Connexin mutations in deafness. Nature 1998, 394, 630-631.
114. Ramensky, V.; Bork, P.; Sunyaev, S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002, 30, 3894-3900.
115. Binkley, J.; Karra, K.; Kirby, A.; Hosobuchi, M.; Stone, E.A.; Sidow, A. ProPhylER: a curated online resource for protein function and structure based on evolutionary constraint analyses. Genome Res. 2010, 20, 142-154.
116. Matthews, L.; Gopinath, G.; Gillespie, M.; Caudy, M.; Croft, D.; de Bono, B.; Garapati, P.; Hemish, J.; Hermjakob, H.; Jassal, B.; Kanapin, A.; Lewis, S.; Mahajan, S.; May, B.; Schmidt, E.; Vastrik, I.; Wu, G.; Birney, E.; Stein, L.; D'Eustachio, P. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 2009, 37, D619-622.
117. Bauer-Mehren, A.; Furlong, L.I.; Rautschka, M.; Sanz, F. From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways. BMC Bioinformatics 2009, 10 (Suppl. 8), S6.
118. Khoury, M.J.; McBride, C.M.; Schully, S.D.; Ioannidis, J.P.; Feero, W.G.; Janssens, A.C.; Gwinn, M.; Simons-Morton, D.G.; Bernhardt, J.M.; Cargill, M., et al. The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet. Med. 2009, 11, 559-567.
119. Sconce, E.A.; Khan, T.I.; Wynne, H.A.; Avery, P.; Monkhouse, L.; King, B.P.; Wood, P.; Kesteven, P.; Daly, A.K.; Kamali, F. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood 2005, 106, 2329-2333.
120. Anderson, J.L.; Horne, B.D.; Stevens, S.M.; Grove, A.S.; Barton, S.; Nicholas, Z.P.; Kahn, S.F.; May, H.T.; Samuelson, K.M.; Muhlestein, J.B.; Carlquist, J.F. Randomized trial of genotypeguided versus standard warfarin dosing in patients initiating oral anticoagulation. Circulation 2007, 116, 2563-2570.
121. Caraco, Y.; Blotnick, S.; Muszkat, M. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study. Clin. Pharmacol. Ther. 2008, 83, 460-470.
122. Hillman, M.A.; Wilke, R.A.; Yale, S.H.; Vidaillet, H.J.; Caldwell, M.D.; Glurich, I.; Berg, R.L.; Schmelzer, J.; Burmester, J.K. A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. Clin. Med. Res. 2005, 3, 137-145.
123. Klein, T.E.; Altman, R.B.; Eriksson, N.; Gage, B.F.; Kimmel, S.E.; Lee, M.T.; Limdi, N.A.; Page, D.; Roden, D.M.; Wagner, M.J.; Caldwell, M.D.; Johnson, J.A. Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med. 2009, 360, 753-764.
124. Woodcock, J.; Lesko, L.J. Pharmacogenetics--tailoring treatment for the outliers. N. Engl. J. Med. 2009, 360, 811-813.
125. Eby, C.S. Counterpoint: pharmacogenetic-based initial dosing of warfarin: not ready for prime time. Clin. Chem. 2009, 55, 712-714.
126. Flockhart, D.A.; O'Kane, D.; Williams, M.S.; Watson, M.S.; Gage, B.; Gandolfi, R.; King, R.; Lyon, E.; Nussbaum, R.; Schulman, K.; Veenstra, D. Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet. Med. 2008, 10, 139-150.
127. Kraft, P.; Cox, D.G. Study designs for genome-wide association studies. Adv. Genet. 2008, 60, 465-504.
128. Nakaoka, H.; Inoue, I. Meta-analysis of genetic association studies: methodologies, betweenstudy heterogeneity and winner's curse. J. Hum. Genet. 2009, 54, 615-623.
129. Raychaudhuri, S.; Plenge, R.M.; Rossin, E.J.; Ng, A.C.; Purcell, S.M.; Sklar, P.; Scolnick, E.M.; Xavier, R.J.; Altshuler, D.; Daly, M.J. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 2009, 5, e1000534.
130. Clayton, E.W. Ethical, legal, and social implications of genomic medicine. N. Engl. J. Med. 2003, 349, 562-569.